Hans Jansen

Hans Jansen is the Chief Technology Officer (CTO) at Future Genomics Technologies.1 He is a molecular biologist with extensive experience, particularly focusing on next-generation sequencing, bioinformatics, and high-throughput compound screens.1

Professional Background

As a CTO, Hans Jansen likely plays a crucial role in shaping the technological direction and strategy of Future Genomics Technologies. His expertise in molecular biology and advanced genomic technologies positions him well to lead the company's technical initiatives and innovations in the field of genomics.

Areas of Expertise

Hans Jansen's professional focus encompasses several key areas in modern genomics and biotechnology:

1. Next-generation sequencing: This technology allows for rapid and cost-effective DNA sequencing, crucial for many genomics applications.
2. Bioinformatics: The use of computational methods to analyze biological data, particularly important in processing and interpreting large genomic datasets.
3. High-throughput compound screens: A method used in drug discovery and other biotechnology applications to rapidly test large numbers of chemical compounds for biological activity.

These areas of expertise suggest that Hans Jansen is at the forefront of cutting-edge genomic technologies and their applications in research and potentially in clinical settings.